| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS G EUR CAP | RVI EMERGENTES | 28,58% | 49,93% | · | · |
| DWS INVEST CROCI EURO IC | RV EURO | 28,57% | 36,09% | 54,47% | · |
| WELLINGTON EMERGING MARKETS RESEARCH EQUITY D EUR ACC | RVI EMERGENTES | 28,57% | 43,75% | 9,85% | · |
| MAN JAPAN COREALPHA EQUITY I EUR NET-DIS A | RVI JAPÓN | 28,55% | 65,41% | · | · |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND R USD HEDGED | RVI JAPÓN VALOR | 28,55% | 125,85% | · | · |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS AQNG EUR DIS | RVI EMERGENTES | 28,55% | 47,22% | 8,16% | · |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS NG EUR CAP | RVI EMERGENTES | 28,54% | 49,78% | · | · |
| BGF EMERGING MARKETS EQUITY INCOME A6 CAD (HEDGED) | RVI EMERGENTES | 28,52% | 28,02% | -5,60% | · |
| DWS INVEST CROCI EURO TFC | RV EURO | 28,52% | 35,93% | 54,20% | · |
| GVC GAESCO CROSSOVER / GLOBAL MOMENTUM RV + RF F | MIXTO FLEXIBLE | 28,52% | 114,48% | · | · |
| PICTET - BIOTECH P EUR | BIOTECNOLOGÍA | 28,52% | 51,99% | 25,31% | 110,75% |
| SCHRODER ISF EMERGING EUROPE IZ ACC EUR | RVI EMERGENTES EUROPA | 28,51% | · | -7,67% | · |
| ABRDN SICAV I-CHINA A SHARE SUSTAINABLE EQUITY FUND X ACC EUR HEDGED | RVI CHINA | 28,49% | -4,29% | -41,33% | · |
| JPM EMERGING MARKETS OPPORTUNITIES I (ACC) EUR | RVI EMERGENTES | 28,49% | 45,64% | 6,96% | 159,54% |
| MSIF SUSTAINABLE EMERGING MARKETS EQUITY Z (EUR) | RVI EMERGENTES | 28,49% | · | · | · |
| NOMURA FUNDS IRELAND - JAPAN STRATEGIC VALUE FUND I USD HEDGED | RVI JAPÓN VALOR | 28,49% | 124,50% | 206,68% | 364,04% |
| WCM GLOBAL EMERGING MARKETS EQUITY H-R/A (EUR) | RVI EMERGENTES | 28,49% | 44,23% | -12,12% | · |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME I CAP USD | RVI EMERGENTES | 28,48% | 62,63% | 26,66% | 146,41% |
| SCHRODER ISF GLOBAL RECOVERY C ACC GBP (HEDGED) | RVI GLOBAL VALOR | 28,48% | 61,58% | 71,78% | 131,78% |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR | BIOTECNOLOGÍA | 28,47% | 73,87% | · | · |
